Patents-Review.com
🔗 Permalink
Assignee profile:

Janssen Pharmaceutical N.V.

City:

Beerse

Country:

Belgium

Published Applications:

17

Last publication date:

2017-11-09

Patent Grants:

17

Last grant date:

2018-05-29

Top Inventors for applications by Janssen Pharmaceutical N.V.

These are the the leading inventors for applications assigned to Janssen Pharmaceutical N.V.:

Recent patent applications by Janssen Pharmaceutical N.V.

Janssen Pharmaceutical N.V. based in Beerse, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-11-09 ✅ Patent 9,981,919 granted on 2018-05-29
US20170320835A1
Chemistry; metallurgy

HIV replication inhibiting pyrimidines

 #2 | 2017-10-26 ✅ Patent 11,603,403 granted on 2023-03-14
US20170306023A1
Chemistry; metallurgy

Anti-human vista antibodies and use thereof

 #3 | 2017-10-26 ✅ Patent 11,603,402 granted on 2023-03-14
US20170306019A1
Chemistry; metallurgy

Anti-human vista antibodies and use thereof

 #4 | 2015-03-26 ✅ Patent 9,227,935 granted on 2016-01-05
US20150087629A1
Chemistry; metallurgy

Piperidine/piperazine derivatives

 #5 | 2013-12-26 ✅ Patent 9,845,326 granted on 2017-12-19
US20130345228A1
Chemistry; metallurgy

Substituted 3,4-dihydropyrrolo[1,2-A]pyrazines as beta-secretase (BACE) inhibitors

 #6 | 2013-11-21 ✅ Patent 9,062,048 granted on 2015-06-23
US20130310365A1
Chemistry; metallurgy

Cyclohexyl-azetidinyl antagonists of CCR2

 #7 | 2013-11-14 ✅ Patent 8,916,554 granted on 2014-12-23
US20130303506A1
Chemistry; metallurgy

Amino-derivatives as novel inhibitors of histone deacetylase

 #8 | 2011-03-03 ✅ Patent 8,404,683 granted on 2013-03-26
US20110053937A1
Chemistry; metallurgy

Inhibitors of the interaction between MDM2 and P53

 #9 | 2010-09-23 ✅ Patent 9,573,933 granted on 2017-02-21
US20100240637A1
Human necessities

Inhibitors of the interaction between MDM2 and P53

 #10 | 2008-09-04 ✅ Patent 8,563,591 granted on 2013-10-22
US20080214597A1
Chemistry; metallurgy

Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

 #11 | 2008-05-08 ✅ Patent 7,915,249 granted on 2011-03-29
US20080108599A1
Chemistry; metallurgy

Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HTinhibitors in the treatment of CNS disorders

 #12 | 2007-04-12 ✅ Patent 7,528,154 granted on 2009-05-05
US20070082888A1
Chemistry; metallurgy

Polyarylcarboxamides useful as lipid lowering agents

 #13 | 2006-08-24 ✅ Patent 7,645,755 granted on 2010-01-12
US20060189623A1
Chemistry; metallurgy

Inhibitors of c-fms kinase

 #14 | 2005-11-17 ✅ Patent 7,244,866 granted on 2007-07-17
US20050256203A1
Chemistry; metallurgy

Carboxamido opioid compounds

 #15 | 2005-10-06 ✅ Patent 7,423,147 granted on 2008-09-09
US20050222151A1
Chemistry; metallurgy

Pyridine compounds as histamine H3 modulators

 #16 | 2005-06-09 ✅ Patent 7,301,050 granted on 2007-11-27
US20050124698A1
Human necessities

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

 #17 | 2005-02-03 ✅ Patent 7,351,711 granted on 2008-04-01
US20050026917A1
Chemistry; metallurgy

Tricyclic indanyls as integrin inhibitors

Also check out Janssen Pharmaceutical NV's (Beerse, Belgium) applicant profile with 5 patent applications submitted.

AssigneeID:

45417 ⎘